Overview
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, characterized by four structural abnormalities of the heart: a ventricular septal defect (VSD, a hole between the lower chambers of the heart), overriding aorta (the aorta is positioned over the VSD rather than solely over the left ventricle), right ventricular outflow tract obstruction (RVOTO, narrowing at or near the pulmonary valve that restricts blood flow to the lungs), and right ventricular hypertrophy (thickening of the right ventricle's muscular wall as a consequence of the obstruction). These defects result in oxygen-poor blood being pumped to the body, leading to cyanosis — a bluish discoloration of the skin, lips, and nail beds. TOF is typically diagnosed in the neonatal period or early infancy, often presenting with cyanosis, heart murmurs, and episodes called "tet spells" (hypercyanotic spells), during which the infant becomes suddenly very blue, irritable, and may lose consciousness due to a rapid drop in blood oxygen levels. Feeding difficulties, poor weight gain, and exercise intolerance may also be observed. The severity of symptoms depends largely on the degree of right ventricular outflow tract obstruction; some patients with milder obstruction may initially appear "pink" and present later in infancy. TOF can occur as an isolated cardiac malformation or as part of broader genetic syndromes, including 22q11.2 deletion syndrome (DiGeorge syndrome), trisomy 21 (Down syndrome), and Alagille syndrome. Several genes have been implicated, including NKX2-5, JAG1, TBX1, GATA4, and FOXC2, among others. The condition is treated surgically, with complete intracardiac repair typically performed in the first year of life. This surgery involves closure of the VSD and relief of the right ventricular outflow tract obstruction. Prior to definitive repair, severely cyanotic neonates may require a palliative shunt procedure (such as a Blalock-Taussig shunt) or prostaglandin infusion to maintain blood flow to the lungs. With modern surgical techniques, long-term survival is excellent, though patients require lifelong cardiac follow-up for potential complications including pulmonary regurgitation, arrhythmias, right ventricular dysfunction, and the possible need for pulmonary valve replacement later in life.
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsCairo University — NA
Boston Children's Hospital
Assiut University
The University of Hong Kong — PHASE4
Guy's and St Thomas' NHS Foundation Trust
University Medical Center Goettingen — NA
Weill Medical College of Cornell University — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Tetralogy of Fallot.
14 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Tetralogy of Fallot.
Community
No community posts yet. Be the first to share your experience with Tetralogy of Fallot.
Start the conversation →Latest news about Tetralogy of Fallot
Disease timeline:
New recruiting trial: Repaired Tetralogy of Fallot Italian Registry
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: Quantifying New Heart Muscle Cells
A new clinical trial is recruiting patients for Tetralogy of Fallot
New recruiting trial: Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
A new clinical trial is recruiting patients for Tetralogy of Fallot
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Tetralogy of Fallot
What is Tetralogy of Fallot?
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, characterized by four structural abnormalities of the heart: a ventricular septal defect (VSD, a hole between the lower chambers of the heart), overriding aorta (the aorta is positioned over the VSD rather than solely over the left ventricle), right ventricular outflow tract obstruction (RVOTO, narrowing at or near the pulmonary valve that restricts blood flow to the lungs), and right ventricular hypertrophy (thickening of the right ventricle's muscular wall as a consequence of the obstruction). These defects result
How is Tetralogy of Fallot inherited?
Tetralogy of Fallot follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Tetralogy of Fallot typically begin?
Typical onset of Tetralogy of Fallot is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Tetralogy of Fallot?
Yes — 14 recruiting clinical trials are currently listed for Tetralogy of Fallot on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Tetralogy of Fallot?
25 specialists and care centers treating Tetralogy of Fallot are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.